Clinical Trials Browser

Phase 3 × durvalumab × Gynecologic × Clear all

NCT06746116 2026-01-16

DUoENDE

Phase 3 Active not recruiting

Endometrial Neoplasms

NCT04269200 2025-12-23

DUO-E

Phase 3 Active not recruiting

805 enrolled 18 charts 1 FDA

Endometrial Neoplasms

NCT03737643 2025-01-29

DUO-O

Phase 3 Active not recruiting

1,407 enrolled 2 FDA

Ovarian Neoplasms

NCT03830866 2024-07-26

CALLA

Phase 3 Completed

770 enrolled 12 charts

Locally Advanced Cervical Cancer